Perspective Therapeutics, Inc. (CATX) Insider Trading

Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company is its CS-1 Cesium-131 brachytherapy seeds. This treatment is specifically utilized for a broad range of cancers, such as those impacting the prostate, brain, lung, head and neck regions, gynecological system, pelvic/abdominal areas, and colorectal tissues. The company distributes its products to medical facilities and physician practices equipped with surgical capabilities. The entity originally operated under the name Isoray, Inc., before officially adopting the name Perspective Therapeutics, Inc. in February 2022. Founded in 1998, the company maintains its corporate headquarters in Richland, Washington.

Showing latest transactions and SEC Form 4 filings for CATX.

8 results.

X Filing Date Trade Date Ticker Company Name Insider Name Title Trade Type Price Qty Owned ΔOwn Value
2026-11-17 08:30:04 2026-11-16 CATX Perspective Therapeutics, Inc. Morich Frank Director P - Purchase $0.94 +15,000 30,000 +100% +$14,046
2026-11-16 08:30:06 2026-11-12 CATX Perspective Therapeutics, Inc. Morich Frank Director P - Purchase $1.00 +15,000 15,000 0% +$14,957
M 2026-11-16 08:30:05 2026-11-12 CATX Perspective Therapeutics, Inc. Williamson Robert F III Director P - Purchase $0.84 +24,898 143,744 +5% +$20,906
2026-11-16 08:30:03 2026-11-12 CATX Perspective Therapeutics, Inc. Woods Lori A Director P - Purchase $0.84 +23,750 212,017 +13% +$20,040
M 2026-11-13 08:30:04 2026-11-12 CATX Perspective Therapeutics, Inc. Puhlmann Markus Chief Medical Officer P - Purchase $0.84 +41,000 322,084 +12% +$34,545
2026-11-12 08:30:03 2026-11-11 CATX Perspective Therapeutics, Inc. Spoor Johan M. Chief Executive Officer, Director P - Purchase $0.81 +47,000 134,683 +54% +$37,943